A study was carried out to assess how best to help patients with chronic kidney disease (CKD) make informed decisions about which type of dialysis they prefer.

Decision-making tools (DMTs) are considered to be the gold-standard in enabling such informed choice, but are still not widely used. In this study, 2,012 patients across 48 of our clinics were empowered with the DMTs process, 71% being medically suitable for both techniques. In order to help them decide whether to start on PD, a variety of resources were offered such as patient values evaluation, written information, a DVD and visits to clinics where both haemodialysis and peritoneal dialysis (PD) were carried out.

A shared decision was taken, aligned with relatives, in 82% of cases. Most patients (92%) felt the process useful in their journey towards making a choice. Of patients suitable for both modalities, 35% chose PD, whilst chronic ascription to a PD program occurred in 31%.

Download a poster here or below of the study in short.

News

Growth

Diaverum Uruguay opens new clinic in Lagomar

Care, true care

Diaverum Poland receives ‘Medical Lens’ 2023 award

Growth

Diaverum Sweden awarded new contract in Stockholm